The Williams Companies Inc.

03/26/2025 | Press release | Archived content

Soleno Therapeutics Announces U.S. FDA Approval of VYKAT™ XR to Treat Hyperphagia in Prader-Willi Syndrome

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.
The Williams Companies Inc. published this content on March 26, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on April 03, 2025 at 21:56 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]